Boston Scientific (BSX) Stock Sinks As Market Gains: What You Should Know

Boston Scientific (BSX) declined 1.46% to $42.60, underperforming the broader market which gained 0.73%. The stock has lost 7.92% over the past month. While analysts expect modest earnings growth of 1.33% YoY and revenue growth of 3.25% for the upcoming quarter, the company received a Zacks Rank #4 (Sell) rating due to a 1.3% downward revision in consensus EPS estimates over the last 30 days. However, the stock trades at a discount with a Forward P/E of 13.28 versus the industry average of 19.67.